Back to search

Article

The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data

2023-03-24

Abstract excerpt

<h4>Background: </h4> Neoadjuvant chemotherapy (NACT) becomes the first-line option for advanced tumors, while patients who are not sensitive to it may not benefit. Therefore, it is important to screen patients suitable for NACT. <h4>Methods: </h4> Single-cell data of lung adenocarcinoma (LUAD) and esophageal squamous carcinoma (ESCC) before and after cisplatin-containing (CDDP) NACT and cisplatin IC50 data of tu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7bde1d02-f00f-5dbe-bb31-27ac937cef57
DOI
10.21203/rs.3.rs-2686396/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell dataDOI 10.21203/rs.3.rs-2686396/v1
Select a neighboring publication to make it the new centre.